Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
Go back to Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies| (NASDAQ: QNRX) | Delayed: 3.90 -0.13 (3.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.03 | 52 Week High | $ | |||
| Open | $4.00 | 52 Week Low | $ | |||
| Day High | $4.11 | P/E | N/A | |||
| Day Low | $3.90 | EPS | $ | |||
| Volume | 31,741 | |||||
| Skinvisible, Inc. (AMEX: SKVI) | Delayed: 0.16 -0.04 (20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.20 | 52 Week High | $0.04 | |||
| Open | $0.16 | 52 Week Low | $0.00 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $-0.01 | |||
| Volume | 905 | |||||



